| Entry |
|
|---|
| Name |
Etaracizumab (USAN/INN);
Abegrin (TN)
|
|---|
| Formula |
C6392H9908N1732O1996S42
|
|---|
| Exact mass |
144211.5312
|
|---|
| Mol weight |
144300.2007
|
|---|
| Activity |
Treatment of metastatic melanoma, prostate cancer
|
|---|
| Comment |
Monoclonal antibody
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Others
Cell adhesion molecules (CAMs)
integrin alphav/beta3 (VNR) [HSA:3685 3690] [KO:K06487 K06493]
Etaracizumab
D09342 Etaracizumab (USAN/INN)
 |
|---|
| Other DBs |
|
|---|
